Priobiodrug compounds its funding with another $19m

Jan 5, 2012 • Robert Lavine

Germany-based biopharmaceutical company Probiodrug secured €15m ($19.2m) in funding on Wednesday from investors including Biogen Idec New Ventures, a corporate venturing unit belonging to pharmaceutical corporation Biogen Idec, and biotechnology investment company BB Biotech.

Also investing in the round were Edmond de Rothschild Investment Partners, which acts as a division of the Edmond de Rothschild banking group, venture capital (VC) firms Life Science Partners and TVM Capital, investment holding company HBM BioVentures, investment fund Goodvent/ IBG and new investor…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.

Find out more

FUNDING ROUND DATA

Which corporates are backing which startups? Search our corporate deal database.

RISING STARS

Introducing the GCV Rising Stars 2024

EMERGING LEADERS

Introducing the GCV Emerging Leaders 2024

Events

GCV Institute: Landing the Value of Corporate Venturing

May 6 -
May 9, 2024
Online

Find out more All events

Events

Webinar: CVCs and the art of the follow-on

May 8, 2024
Online

Find out more All events

Events

GCV Institute: CVC Investment Programs

May 21 -
May 22, 2024
Online

Find out more All events

Events

GCV Symposium 2024

Jun 24 -
Jun 26, 2024
London (UK)

Find out more All events

Events

Corporate Venture in Brasil 2024 – International Delegation to Brazil

Oct 28 -
Oct 30, 2024
São Paulo (Brazil)

Find out more All events

About us

GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.